Browsing by Author Auladell, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 28  next >
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
Aging biology: A new frontier for drug discoveryVerdaguer, E.; Junyent, F.; Folch, J.; Beas-Zárate, Carlos; Auladell, C.; Pallas, M.; Camins, A.--
Aging biology: A new frontier for drug discoveryVerdaguer, E.; Junyent, F.; Folch, J.; Beas-Zárate, Carlos; Auladell, C.; Pallas, M.; Camins, A.--
Antiapoptotic drugs: A therapautic strategy for the prevention of neurodegenerative diseasesSureda, F.X.; Junyent, F.; Verdaguer, E.; Auladell, C.; Pelegri, C.; Vilaplana, J.; Folch, J.; Canudas, A.M.; Zarate, C.B.; Pallas, M.; Camins, A.--
Antiapoptotic drugs: A therapautic strategy for the prevention of neurodegenerative diseasesSureda, F.X.; Junyent, F.; Verdaguer, E.; Auladell, C.; Pelegri, C.; Vilaplana, J.; Folch, J.; Canudas, A.M.; Zarate, C.B.; Pallas, M.; Camins, A.--
Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cellsPizarro, J.G.; Folch, J.; Junyent, F.; Verdaguer, E.; Auladell, C.; Beas-Zárate, Carlos; Pallas, M.; Camins, A.--
Antiapoptotic effects of roscovitine on camptothecin-induced DNA damage in neuroblastoma cellsPizarro, J.G.; Folch, J.; Junyent, F.; Verdaguer, E.; Auladell, C.; Beas-Zárate, Carlos; Pallas, M.; Camins, A.--
Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's diseasePedros, I.; Petrov, D.; Allgaier, M.; Sureda, F.; Barroso, E.; Beas-Zárate, Carlos; Auladell, C.; Pallas, M.; Vazquez-Carrera, M.; Casadesus, G.; Folch, J.; Camins, A.--
Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's diseasePedros, I.; Petrov, D.; Allgaier, M.; Sureda, F.; Barroso, E.; Beas-Zárate, Carlos; Auladell, C.; Pallas, M.; Vazquez-Carrera, M.; Casadesus, G.; Folch, J.; Camins, A.--
Evaluation of hypoxia inducible factor expression in inflammatory and neurodegenerative brain modelsDe Lemos, M.L.; De La Torre, A.V.; Petrov, D.; Brox, S.; Folch, J.; Pallas, M.; Lazarowski, A.; Beas-Zárate, Carlos; Auladell, C.; Camins, A.--
Evaluation of hypoxia inducible factor expression in inflammatory and neurodegenerative brain modelsDe Lemos, M.L.; De La Torre, A.V.; Petrov, D.; Brox, S.; Folch, J.; Pallas, M.; Lazarowski, A.; Beas-Zárate, Carlos; Auladell, C.; Camins, A.--
Gene expression profile in JNK3 null mice: A novel specific activation of the PI3K/AKT pathwayJunyent, F.; De Lemos, L.; Verdaguer, E.; Folch, J.; Ferrer, I.; Ortuno-Sahagun, D.; Beas-Zárate, Carlos; Romero, R.; Pallas, M.; Auladell, C.; Camins, A.--
Gene expression profile in JNK3 null mice: A novel specific activation of the PI3K/AKT pathwayJunyent, F.; De Lemos, L.; Verdaguer, E.; Folch, J.; Ferrer, I.; Ortuno-Sahagun, D.; Beas-Zárate, Carlos; Romero, R.; Pallas, M.; Auladell, C.; Camins, A.--
GSK3? inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neuronsDe La Torre, A.V.; Junyent, F.; Folch, J.; Pelegri, C.; Vilaplana, J.; Auladell, C.; Beas-Zárate, Carlos; Pallas, M.; Verdaguer, E.; Camins, A.--
GSK3β inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neuronsDe La Torre, A.V.; Junyent, F.; Folch, J.; Pelegri, C.; Vilaplana, J.; Auladell, C.; Beas-Zárate, Carlos; Pallas, M.; Verdaguer, E.; Camins, A.--
Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acidJunyent, F.; de Lemos, L.; Verdaguer, E.; Pallas, M.; Folch, J.; Beas-Zárate, Carlos; Camins, A.; Auladell, C.--
Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acidJunyent, F.; de Lemos, L.; Verdaguer, E.; Pallas, M.; Folch, J.; Beas-Zárate, Carlos; Camins, A.; Auladell, C.--
Mavoglurant as a treatment for Parkinson's diseasePetrov, D.; Pedros, I.; De Lemos, M.L.; Pallas, M.; Canudas, A.M.; Lazarowski, A.; Beas-Zárate, Carlos; Auladell, C.; Folch, J.; Camins, A.--
Mavoglurant as a treatment for Parkinson's diseasePetrov, D.; Pedros, I.; De Lemos, M.L.; Pallas, M.; Canudas, A.M.; Lazarowski, A.; Beas-Zárate, Carlos; Auladell, C.; Folch, J.; Camins, A.--
Microarray analysis of rat hippocampus exposed to excitotoxicity: Reversal Na +/Ca 2+ exchanger NCX3 is overexpressed in glial cellsOrtuno-Sahagun, D.; Rivera-Cervantes, M.C.; Gudino-Cabrera, G.; Junyent, F.; Verdaguer, E.; Auladell, C.; Pallas, M.; Camins, A.; Beas-Zárate, Carlos--
Microarray analysis of rat hippocampus exposed to excitotoxicity: Reversal Na +/Ca 2+ exchanger NCX3 is overexpressed in glial cellsOrtuno-Sahagun, D.; Rivera-Cervantes, M.C.; Gudino-Cabrera, G.; Junyent, F.; Verdaguer, E.; Auladell, C.; Pallas, M.; Camins, A.; Beas-Zárate, Carlos--